Agios Pharmaceuticals | AGIO - إيرادات الفوائد





إيرادات الفوائد تغيير تاريخ
AbbVie USD 59M 13M 2025-12
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Arrowhead Research USD 9.05M 1.97M 2025-09
Astellas Pharma JPY 4.12B 2.94B 2024-03
AstraZeneca USD 135M 50M 2025-12
Bayer EUR 130M 38M 2025-09
Biogen USD 37.2M 5.6M 2025-12
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Exelixis USD 15.92M 867K 2025-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP -74M 100M 2025-12
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Merck USD 96M 27M 2025-09
Moderna USD 73M 8M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.62 156M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09